Page last updated: 2024-11-06

tertiary-amyl methyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tertiary-amyl methyl ether: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61247
CHEMBL ID1359297
SCHEMBL ID67637
MeSH IDM0254279

Synonyms (49)

Synonym
butane, 2-methoxy-2-methyl-
ether, methyl tert-pentyl
einecs 213-611-4
methyl tert-amyl ether
tertiary amyl methyl ether
ccris 7266
methyl 1,1-dimethylpropyl ether
2-methoxy-2-methylbutane
tert-amyl methyl ether
tame (ether)
methyl tert-pentyl ether
tertiary-amyl methyl ether
2-methyl-2-methoxybutane
ai3-04349
tert-pentyl methyl ether
994-05-8
NCGC00091829-01
tertiary amyl methyl ether (tame)
tert-amyl methyl ether, analytical standard
tert-amyl methyl ether, 97%
1,1-dimethylpropyl methyl ether
t-amyl methyl ether
NCGC00091829-02
ec 213-611-4
94525j1ap8 ,
unii-94525j1ap8
hsdb 7869
dtxcid404521
NCGC00258706-01
cas-994-05-8
dtxsid8024521 ,
tox21_201154
methyl 2-methyl-2-butyl ether
AKOS015915748
amyl methyl ether, tert-
tert-amyl methyl ether [mi]
SCHEMBL67637
tert. amyl methyl ether
methyl t-amyl ether
2-methoxy-2-methyl-butane
CHEMBL1359297
2-methoxy-2-methylbutane #
FT-0699292
tert-amyl methyl ether, purum, absolute, over molecular sieve (h2o <=0.005%), >=97.0% (gc)
tert-amyl-methyl ether
Q4346419
tert-amylmethylether
tert-amyl-methylether
mfcd00010186

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Preliminary test data indicated that the acute oral LD50 for TAME in Sprague-Dawley rats was ca."( Genotoxicity and twenty-eight-day subchronic toxicity studies on tertiary amyl methyl ether.
Bird, MG; Daughtrey, WC,
)
0.13
"Under Office of Prevention, Pesticides and Toxic Substances draft guidelines, CD weanling F0 rats (30 of each gender per group) inhaled tertiary amyl methyl ether vapor at 0, 250, 1500 or 3000 ppm 5 days a week and 6 h a day for 10 weeks, with vaginal cytology evaluated for weeks 8-10."( Two-generation reproductive toxicity study of inhaled tertiary amyl methyl ether (TAME) vapor in CD rats.
Elswick, B; Fail, PA; James, A; Marr, MC; Myers, CB; Seely, JC; Tyl, RW; Welsch, F,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency56.23410.004023.8416100.0000AID485290
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency12.58930.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency21.57970.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency43.45440.000817.505159.3239AID1159527
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.46330.000229.305416,493.5996AID743075; AID743079
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency4.46680.00798.23321,122.0200AID2546
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (23.68)18.2507
2000's17 (44.74)29.6817
2010's12 (31.58)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.94 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (4.35%)5.53%
Reviews2 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (91.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]